Zurueck zur Suche

Reporte zur Charge UJ7725AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
PA 2

VAERS 1813067

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ7725AA

gering
Staat
PA
Alter
-
Geschlecht
F
Eingang
23.10.2021
Impfdatum
12.10.2021
Beginn
12.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

A patient asked for B12 shot and received the flu vaccine/ no AE; The patient received a flu vaccine had a flu vaccine a month ago too/ no AE; Initial information regarding an unsolicited valid non-serious case was received from other health care professional via Agency (Reference number- 00811175) and transmitted to Sanofi on 13-Oct-2021. This case is linked to case 2021SA342362 (same reporter). This case involves a 64-year-old female patient who received a 0.5 mL (once) dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (lot UJ7725AA, expiry date 30-Jun-2022) via intramuscular route in the right arm on 12-Oct-2021 for prophylactic vaccination instead of CYANOCOBALAMIN [B12 shot] (wrong product administered) and she had a flu vaccine a month ago too (extra dose administered). The patient's medical history included Renal transplant. The patient's past medical treatment(s), vaccination(s) and family history were not provided. It was a case of an actual medication error due to wrong vaccine administered and extra dose administered (latency was on same day). It was reported "Medical assistant reports two patients who are husband and wife came in for B12 shot and received the flu vaccine. They both had the flu vaccine a month ago. She asks for appropriate follow-up." No other adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Renal transplant
Andere Medikamente
CYANOCOBALAMIN
Allergien
-
Vorherige Impfungen
-

VAERS 1813066

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ7725AA

gering
Staat
PA
Alter
70,0
Geschlecht
M
Eingang
23.10.2021
Impfdatum
12.10.2021
Beginn
12.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

A patient asked for B12 shot and received the flu vaccine no AE; The patient received a flu vaccine had a flu vaccine a month ago no AE; Initial information regarding an unsolicited valid non-serious case was received from other health care professional via Regulatory authority (Reference number- 00811126) and transmitted to Sanofi on 13-Oct-2021. This case is linked to case 2021SA343570 (same reporter). This case involves a 70-year-old male patient who was received INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] and had a flu vaccine a month ago too (extra dose administered) instead of CYANOCOBALAMIN [B12 shot] (wrong product administered). The patient's medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 12-Oct-2021, the patient received a 0.5 mL dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot UJ7725AA, expiry: 30-Jun-2022) via intramuscular route in the right arm for prophylactic vaccination instead of CYANOCOBALAMIN [b12 shot]. It was a case of an actual medication error due to wrong vaccine administered and extra dose administered (latency same day). It was reported "Medical assistant reports two patients who are husband and wife came in for B12 shot and received the flu vaccine. They both had the flu vaccine a month ago. She asks for appropriate follow-up. She asks what specifically to monitor for and also any information regarding one patient has history of renal transplant." No other adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
CYANOCOBALAMIN
Allergien
-
Vorherige Impfungen
-